Publications by authors named "Yasuko Enomoto"
Article Synopsis
- DYRK2 is a kinase that affects the degradation of TERT, a protein linked to cancer, and this study explored their expressions in breast cancer patients to predict recurrence.
- The analysis involved 221 early breast cancer patients, and researchers used immunohistochemical methods to examine DYRK2 and TERT levels and their relationship to clinical outcomes.
- Findings showed that DYRK2 positivity was linked to better disease-free survival, while TERT positivity indicated worse survival; combining both markers may help better classify breast cancer patients.
This study investigated the potential of DYRK2, a dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase gene, to predict disease-free survival for patients with early stage breast cancer. Two hundred and seventy-four patients with breast cancer underwent surgery from January 2000 to December 2009. All patients were in stage I or II.
View Article and Find Full Text PDFBackground: The surgical treatment of early breast cancer has proceeded to less invasive approaches with better cosmetic results. The current study was undertaken to evaluate the clinical and pathological findings after radiofrequency ablation (RFA) without resection for a longer period of time.
Method: A total of 14 patients with breast cancer were enrolled.